0001365916-21-000056.txt : 20210804
0001365916-21-000056.hdr.sgml : 20210804
20210804165651
ACCESSION NUMBER: 0001365916-21-000056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210802
FILED AS OF DATE: 20210804
DATE AS OF CHANGE: 20210804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Melo John
CENTRAL INDEX KEY: 0001501907
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34885
FILM NUMBER: 211144903
MAIL ADDRESS:
STREET 1: C/O AMYRIS, INC.
STREET 2: 5885 HOLLIS ST., SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYRIS, INC.
CENTRAL INDEX KEY: 0001365916
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 550856151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-0761
MAIL ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC
DATE OF NAME CHANGE: 20060613
4
1
wf-form4_162811058889715.xml
FORM 4
X0306
4
2021-08-02
0
0001365916
AMYRIS, INC.
AMRS
0001501907
Melo John
C/O AMYRIS, INC.
5885 HOLLIS STREET, SUITE 100
EMERYVILLE
CA
94608
1
1
0
0
President and CEO
Performance-based Restricted Stock Units
2021-08-02
4
A
0
6000000
0
A
Common Stock
6000000.0
6000000
D
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
Represents a performance-based restricted stock unit award ("PSU") that vests based on achievement of four specified stock price performance targets over a four-year period, as approved by the Issuer's stockholders at a special meeting on July 26, 2021. Concurrently with this PSU grant, the Reporting Person's 3,250,000 performance-based stock options granted on May 29, 2018 were automatically cancelled in full.
/s/ John Melo by Bruna Lawant, Attorney-in-Fact
2021-08-04